A method for predicting prognosis in autoimmune diseases including lupus and ANCA-associated vasculitis. The technique enables patients to be divided into groups at high and low risk of disease progression to identify patients requiring intensive immunosuppressive therapy or to reduce the total immunosuppressive load in patients at low risk of disease relapse.

« Back to all licences